MedTrace Logo

Evaluation of an Intensive Inpatient Psychotherapy Treatment for Severely and Early Traumatized Children (MOSES)

NCT03894774 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2020-02-20

No results posted yet for this study

Summary

Evaluation of longitudinal treatment effects applying an intensive psychotherapeutic intervention for inpatients (age of participants: 6-13 years) with a multi-method-approach to address the complex nature of severe childhood trauma. (Chronic Post-Traumatic Stress Disorder)

Conditions

  • Stress Disorders, Post-Traumatic

Interventions

BEHAVIORAL

Intensive in-patient psychotherapy treatment

Intensive non-pharmaceutical in-patient intervention with high degrees of individual psychotherapy (5 sessions a week, psychodynamic and specific trauma therapy), group therapy (music-, arts-, sports- and concentrative movement therapy - each one session a week) as well as an ongoing milieutherapeutic setting where patients live during the whole treatment (approximately a 1:1-Ratio caregiver per patient is given) of 6 to 8 month treatment duration.

OTHER

Treatment as usual

Combination of behavioral or psychoanalytic outpatient psychotherapy and pharmacotherapy

Sponsors & Collaborators

  • Max-Planck-Institute of Psychiatry

    collaborator OTHER

  • LMU Klinikum

    lead OTHER

Principal Investigators

  • Ludwig Ebeling, M.A. · Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich

  • Catherina Dehmel, M.sc. · Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich

  • Lukas Oberschneider, MD · Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
6 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-05
Primary Completion
2017-10-17
Completion
2019-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03894774 on ClinicalTrials.gov